Abstract: In one aspect, there is provided a method that includes receiving, at a processor executing a machine learning model, an input set comprising a measurement of urine output and a time value indicative of time remaining from when the first measurement is performed until a goal time when a target urine output should be reached; predicting, by the machine learning model and using at least the measurement and the time value, an estimated urine output at the goal time; comparing the estimated urine output at the goal time to the target urine output; and generating, based on the comparing of the target urine output and the estimated urine output predicted by the machine learning model, an alert regarding whether the target urine output will be reached by the goal time. Related systems and computer program products are also provided.

Abstract: The approved email generation system described is capable of producing email communications using approved email templates and content that have been aligned with information regarding user access to such content. Once the approved email has been generated, the content may be verified again for accuracy and validity before being delivered to the user. When the user accesses delivered content, the approved email generation system again verifies the content and allows the user access to only the most current version of the content available. The system provides for control of the content of electronic communications to users.

Abstract: The approved email generation system described is capable of producing email communications using approved email templates and content that have been aligned with information regarding user access to such content. Once the approved email has been generated, the content may be verified again for accuracy and validity before being delivered to the user. When the user accesses delivered content, the approved email generation system again verifies the content and allows the user access to only the most current version of the content available. The system provides for control of the content of electronic communications to users.

Abstract: The approved email generation system described is capable of producing email communications using approved email templates and content that have been aligned with information regarding user access to such content. Once the approved email has been generated, the content may be verified again for accuracy and validity before being delivered to the user. When the user accesses delivered content, the approved email generation system again verifies the content and allows the user access to only the most current version of the content available. The system provides for control of the content of electronic communications to users.

Abstract: Systems and methods for collecting medical data which may allow a sponsor to receive clinical trial data from one or more clinical trial sites electronically. A definition of a clinical trial may be generated by a sponsor and published to the one or more clinical sites. The definition of the clinical trial may define requirements and the workflow of a clinical trial. The definition may be saved as objects in the medial data management system. When users at clinical trial sites log into the medical data management system, a user interface may be generated based on one or more of the objects for receiving clinical trial source data. The clinical trial source data may be aggregated and obfuscated to remove patient defining information. The aggregated and obfuscated data may be sent to the sponsor and stored in the medical data management system as EDC data.

Abstract: Systems and methods for collecting medical data which may allow a sponsor to receive EDC data from one or more clinical trial sites. A definition of a clinical trial may be generated by a sponsor and published to the one or more clinical sites. The definition of the clinical trial may define requirements and the workflow of a clinical trial. A medical data management system may determine the EDC data requirements in the definition of the clinical trial, including required clinical trial source data for generating the EDC data. The medical data management system may identify data in the clinical trial source data that matches the required source data, process the matching source data according to the EDC data requirements to generate the EDC data, and send the EDC data to the sponsor data management system.